BioNTech SE (BNTX) Debt to Equity (2018 - 2021)

BioNTech SE's Debt to Equity history spans 4 years, with the latest figure at $0.14 for Q4 2021.

  • For Q4 2021, Debt to Equity rose 369.28% year-over-year to $0.14; the TTM value through Dec 2021 reached $0.14, up 369.28%, while the annual FY2021 figure was $0.14, 369.28% up from the prior year.
  • Debt to Equity for Q4 2021 was $0.14 at BioNTech SE, up from $0.03 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.23 in Q4 2018 and bottomed at $0.03 in Q4 2020.
  • The 4-year median for Debt to Equity is $0.14 (2019), against an average of $0.14.
  • The largest annual shift saw Debt to Equity plummeted 79.35% in 2020 before it soared 369.28% in 2021.
  • A 4-year view of Debt to Equity shows it stood at $0.23 in 2018, then crashed by 38.76% to $0.14 in 2019, then plummeted by 79.35% to $0.03 in 2020, then surged by 369.28% to $0.14 in 2021.
  • Per Business Quant, the three most recent readings for BNTX's Debt to Equity are $0.14 (Q4 2021), $0.03 (Q4 2020), and $0.14 (Q4 2019).